Industry › BioTech
Press Releases
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Novotech Health Holdings Pte Ltd
Jun 06, 2022 18:00 HKT/SGT
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting
Eisai
Jun 06, 2022 14:05 HKT/SGT
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure
EC Healthcare
Jun 06, 2022 10:35 HKT/SGT
香港中文大学周怡君教授荣获 2022 WIN ADA Award，以表彰其在糖尿病领域的优异研究成果及贡献
The Chinese University of Hong Kong
Jun 05, 2022 09:09 HKT/SGT
香港中文大學周怡君教授榮獲 2022 WIN ADA Award，以表彰其在糖尿病領域的優異研究成果及貢獻
The Chinese University of Hong Kong
Jun 05, 2022 09:08 HKT/SGT
CUHK Professor Elaine Chow Receives "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" for Outstanding Research and Care in Diabetes
The Chinese University of Hong Kong
Jun 05, 2022 09:07 HKT/SGT
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원
Novotech Health Holdings Pte Ltd
Jun 03, 2022 20:00 HKT/SGT
Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting
Eisai
Jun 03, 2022 15:37 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Boehringer Ingelheim
Jun 02, 2022 21:00 HKT/SGT
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Boehringer Ingelheim
Jun 02, 2022 21:00 HKT/SGT
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US
Novotech Health Holdings Pte Ltd
Jun 02, 2022 18:00 HKT/SGT
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Cosmetology Treatment
Sirnaomics Ltd.
May 30, 2022 15:38 HKT/SGT